Yan Song

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Yan Song, Bo Zhang, Dao Xin et al. · Nature Medicine · 2023 · 169 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue

Hao Li, Min Li, Ping Liu et al. · Hypertension · 2016 · 63 citations · Full text

Medicine, Pharmacology, Physiology +16

A functional variant in the 3′-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211

Jingzhou Chen, Tao Yang, Hui Yu et al. · Human Molecular Genetics · 2010 · 52 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia

Koustav Ray, M. Elizabeth Moss, Jeffrey L. Franklin et al. · Oncogene · 2013 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +10

Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway

Xian‐Zhe Dong, Yan Song, Yu-Pan Lu et al. · Journal of Natural Medicines · 2019 · 45 citations

Medicine, Molecular Biology, Oncology +11